Major adverse reactions to yeast-derived hepatitis B vaccines - A review

Vaccine

Volumn 16, Issue 4, 1998, Pages 329-334

  Grotto, I ^c   Mandel, Y ^c   Ephros, M ^a   Ashkenazi, I ^b   Shemer, J ^b  

^a CARMEL MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NONE

Author keywords

Adverse reactions; Hepatitis B vaccine; Review

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

AGE; ANAPHYLAXIS; AUTOIMMUNE HEMOLYTIC ANEMIA; CHRONIC FATIGUE SYNDROME; DRUG DEVELOPMENT; DRUG MANUFACTURE; ERYTHEMA; ERYTHEMA NODOSUM; FATIGUE; FEVER; GLOMERULONEPHRITIS; GUILLAIN BARRE SYNDROME; HEADACHE; HEPATITIS B; HUMAN; INJECTION PAIN; LICHEN PLANUS; MYALGIA; NAUSEA; POLYARTHRITIS; PRIORITY JOURNAL; RASH; REITER SYNDROME; RETINA PIGMENT EPITHELIOPATHY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIC PURPURA; URTICARIA; VASCULITIS; YEAST;

EID: 0032007515     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00214-4     Document Type: Article

References (38)

1. 1 Carmeli, Y. and De-Medina, T. Serious hepatitis B vaccine adverse reactions, are they immune-mediated? [letter]. Vaccine 1993, 11, 1358-1359.
2. 2 Greenberg, D.P. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediat. Infect. Dis. J. 1993, 12, 438-445.
3. 3 Duclos, P. Adverse events after hepatitis B vaccination. Can. Med. Assoc. J. 1992, 147, 1023-1026.
4. 4 Szmuness, W., Stevens, C.E. and Harley, E.J. et al. Hepatitis B vaccine, demonstration of efficacy in a controlled clinical trial, in a high risk population in the United States. N. Engl. J. Med. 1980, 303, 833-841.
5. 5 Immunization Practices Advisory Committee Inactivated hepatitis B virus vaccine. MMWR 1982, 31, 317-328.
6. 6 Centers for Disease Control. Hepatitis B virus, a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination, recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991, 40, 1-25.
7. 7 Andre, F.E. and Safary, A. Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine. Postgrad. Med. J. 1987, 63, (suppl 2), 169-178.
8. 8 CDC. Update: Vaccine side effects, adverse reactions, contraindications and precautions. MMWR 1996, 45, 1-35
9. 9 Andre, F.E. Overview of 5 year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990, 8, (suppl.), 74-78.
10. 10 Stratton, K.R., Howe, C.J. and Johnston, R.B. Jr Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA 1994, 271, 1602-1605.
11. 11 Hudson, T.J., Newkirk, M., Gervais, F. and Suster, J. Adverse reaction to the recombinant hepatitis B vaccine [published erratum appears in J. Allergy Clin. Immunol. 1993, 92, 498]. J. Allergy Clin. Immunol. 1991, 88, 821-822.
12. 12 Goolsby, L.P.G. Erythema Nodosum after Recombivax HB hepatitis B vaccine. N. Engl. J. Med. 1989, 21, 1198-1199.
13. 13 Trevisan, G. and Stinco, G. Lichen ruber planus following HBV vaccination [letter]. Acta Dermato-Venereologica 1993, 73, 73
14. 14 Aubin, F., Angonin, R., Humbert, P. and Agache, P. Lichen planus following hepatitis B vaccination [letter]. Arch. Dermatol. 1994, 130, 1329-1330.
15. 15 Ciaccio, M. and Rebora, A. Lichen Planus following HBV vaccination, a coincidence?. Br. J. Dermatol. 1990, 122, 424
16. 16 Gross, K., Combe, C., Kruger, K. and Schattenkirchner, M. Arthritis after hepatitis B vaccination. Report of three cases. Scand. J. Rheumatol. 1995, 24, 50-52.
17. 17 Rogerson, S. and Nye, F.J. Hepatitis B associated with erythema nodosum and polyarthritis. BMJ 1990, 301, 345
18. 18 Hassan, W. and Oldham, R. Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ 1994, 309, 94
19. 19 Vautier, G. and Carty, J.E. Acute sero-positive Rheumtoid Arthritis occurring after hepatitis vaccination. Br. J. Rheumatol. 1994, 33, 991-998.
20. 20 Allen, M.B., Cockwell, P. and Page, R.L. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax 1993, 48, 580-581.
21. 21 Tudela, P., Marti, S. and Bonal, J. Systemic lupus erythematosus and vaccination against hepatitis B [letter]. Nephron 1992, 62, 236
22. 22 Carmeli, Y. and Oren, R. Hepatitis B vaccine side-effect [letter]. Lancet 1993, 341, 250-251.
23. 23 Martinez, E. and Domingo, P. Evans's syndrome triggered by recombinant hepatitis B vaccine [letter]. Clin. Infect. Dis. 1992, 15, 1051
24. 24 Poullin, P. and Gabriel, B. Thrombocytopenic purpura after recombinant hepatitis B vaccine [letter]. Lancet 1994, 344, 1293
25. 25 Brezin, A.P., Lautier-Frau, M., Hamedani, M., Rogeaux, O. and Lehoang, P. Visual loss and eosinophillia after recombinant hepatitis B vaccine. Lancet 1993, 342, 563-564.
26. 26 Brezin, A.P., Massin-Korobelnik, P., Boudin, M., Gaudric, A. and Lehoang, P. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch. Ophthalmol. 1995, 113, 297-300.
27. 27 Shaw, F.E., Graham, D.J. and Gtuess, H.A. et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am. J. Epidemiol. 1988, 127, 337-352.
28. 28 Trevisani, F., Gattinara, G.C., Caraceni, P. and Bernardi, M. et al. Transverse myelitis following hepatitis B vaccination [letter]. J. Hepatology 1993, 19, 317-318.
29. 29 Herroelen, L., DeKeyser, J. and Ebinger, G. Central nervous system demyelination after immunization with recombinant hepatitis B vaccine. Lancet 1991, 338, 1174-1175.
30. 30 Tartaglino, L.M., Heiman-Pattersson, T., Friedman, D.P. and Flanders, A.E. MR imaging in a case of postvaccination myelitis. AJNR 1995, 16, 581-582.
31. 31 Nadler, J.P. Multiple sclerosis and hepatitis B vaccination [letter]. Clin. Infect. Dis. 1993, 17, 928-929.
32. 32 Deisenhammer, F., Pohl, P., Bosch, S. and Schmidauer, C. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta Neurol. Scand. 1994, 89, 462-463.
33. 33 Report of the working group on the possible relationship between hepatitis B vaccination and the chronic fatigue syndrome. Can. Med. Assoc. J. 1993, 149, 314-319
34. 34 Nowoslowski, A., Krawczynski, K., Nazarewicz, T. and Slusarczyk, T. Immunopathological aspects of hepatitis type B. Am. J. Med. Sci. 1975, 270, 229-239.
35. 35 Gocke, D.J. Extrahepatic manifestations of viral hepatitis. Am. J. Med. Sci. 1975, 270, 49-52.
36. 36 Quast, U., Herder, C. and Zwisler, O. Vaccination of patients with encephalomyelitis disseminata. Vaccine 1991, 9, 228-230.
37. 37 Cosnes, A., Flechet, M.L. and Revuz, J. Inflammatory nodular reactions after hepatitis B vaccination due to aluminum sensitization. Contact Dermatitis 1990, 23, 65-67.
38. 38 Bisno, A.L. Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 1991, 325, 783-793.